Autoliv reports Q2 results on July 17 with short sellers at their most aggressive position in weeks — yet options traders are showing none of the usual pre-earnings anxiety.
The short-side build is the clearest tension heading into Thursday's print. Short interest has climbed 7.2% over the past week to 5.3% of the free float, reversing a month-long decline and bringing positions back to their highest level since early June. The pace of accumulation accelerated noticeably from July 7 onward, with shorts adding roughly 250,000 shares across a six-session run. That rebuilding stands in contrast to the borrow market, which remains entirely untroubled: availability runs at 191% of short interest — meaning there are nearly two shares available to lend for every one already borrowed — and cost to borrow has drifted down 7% on the week to just 0.51%. There is no squeeze pressure here. The short score has nudged up from 53.5 to 56.6 over the past two weeks, consistent with the incremental positioning build, but it sits well inside neutral territory.
Options traders are telling a different story. The put/call ratio has actually eased this week to 0.45, modestly below its 20-day average of 0.47 and a full standard deviation below neutral — if anything, options positioning is leaning slightly more constructive than usual ahead of the print. That divergence matters: shorts are quietly adding exposure while options markets show no particular demand for downside protection. The last Q1 print delivered a 9% one-day gain; the Q4 release saw a 4.7% drop. The range of historical outcomes is wide enough that both camps have precedent on their side.
The Street has been moving more constructively into this print. RBC Capital raised its target to $148 from $138 on July 13 — just two trading days before the release — while maintaining an Outperform rating. That follows Wells Fargo lifting to $122 from $116 in late June, and UBS moving to $122 from $110 in mid-June, both retaining neutral-leaning ratings. The pattern is clear: bulls are raising targets, neutrals are following, and no one has pulled a downgrade since Jefferies moved to Hold back in April. The consensus mean target of $133.82 sits about 10% above Tuesday's close of $121.48, with PE running at 10.6x and EV/EBITDA near 6.4x — undemanding multiples for a company with 45% global market share in passive safety. The dividend score ranks in the 77th percentile, though the dividend history in this snapshot is stale and should not be relied upon for current yield figures.
One institutional holder worth noting is SEB Funds AB, which reported initiating a position of 3.87 million shares — representing over 5% of shares — as recently as July 8. That is a significant new entrant, adding fresh long-side weight just days before earnings. Cevian Capital remains the dominant activist-style holder at 12.4% of shares, unchanged through March. Chairman Jan Carlson sold $2.5 million worth of stock at $130 in mid-June, a transaction that scored relatively low on significance given the price was materially above where the stock trades today.
On the peer front, LEA and THRM both had stronger weeks — up 3.5% and 4.1% respectively — while ADNT barely moved at 0.3%. ALV's 2.1% weekly gain sits roughly in line with the stronger names in the group, suggesting no idiosyncratic drag heading into the release. The real focus now is whether Thursday's Q2 figures — and any commentary on China volumes and tariff cost recovery — shift the balance between the rebuilding shorts and the increasingly constructive analyst community.
See the live data behind this article on ORTEX.
Open ALV on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
